Ryvu Therapeutics S.A. (WSE:RVU)
Poland flag Poland · Delayed Price · Currency is PLN
30.90
-0.10 (-0.32%)
Jul 23, 2025, 5:00 PM CET

Ryvu Therapeutics Revenue

Ryvu Therapeutics had revenue of 21.03M PLN in the quarter ending March 31, 2025, a decrease of -17.27%. This brings the company's revenue in the last twelve months to 97.57M, up 31.13% year-over-year. In the year 2024, Ryvu Therapeutics had annual revenue of 101.96M with 51.51% growth.

Revenue (ttm)
97.57M
Revenue Growth
+31.13%
P/S Ratio
7.30
Revenue / Employee
297.47K
Employees
328
Market Cap
712.10M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024101.96M34.67M51.51%
Dec 31, 202367.30M-1.14M-1.67%
Dec 31, 202268.44M33.02M93.25%
Dec 31, 202135.41M-1.54M-4.16%
Dec 31, 202036.95M3.23M9.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
NEUCA12.82B
Voxel556.98M
Synektik Spólka Akcyjna592.94M
Celon Pharma215.11M
Selvita359.79M
Centrum Medyczne ENEL-MED762.83M
EMC Instytut Medyczny836.81M
Mercator Medical559.42M
Revenue Rankings